| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA5203488
Max Phase: Preclinical
Molecular Formula: C18H17N5O2
Molecular Weight: 335.37
Associated Items:
Representations
Canonical SMILES: O=C(Nc1ncccn1)[C@]12ON=C(c3cccnc3)[C@H]1[C@@H]1CC[C@H]2C1
Standard InChI: InChI=1S/C18H17N5O2/c24-16(22-17-20-7-2-8-21-17)18-13-5-4-11(9-13)14(18)15(23-25-18)12-3-1-6-19-10-12/h1-3,6-8,10-11,13-14H,4-5,9H2,(H,20,21,22,24)/t11-,13+,14-,18-/m1/s1
Standard InChI Key: NNFSUSXMQQHKTB-BFPDHSSHSA-N
Associated Targets(Human)
Cytochrome P450 11B2 2325 Activities
Cytochrome P450 11B1 1750 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 335.37 | Molecular Weight (Monoisotopic): 335.1382 | AlogP: 2.03 | #Rotatable Bonds: 3 |
| Polar Surface Area: 89.36 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 1 |
| #RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 10.66 | CX Basic pKa: 4.21 | CX LogP: 1.74 | CX LogD: 1.74 |
| Aromatic Rings: 2 | Heavy Atoms: 25 | QED Weighted: 0.93 | Np Likeness Score: -0.15 |
References
| 1. Yin L, Pan Y, Xue Y, Chen X, You T, Huang J, Xu Q, Hu Q.. (2022) Design, Synthesis, and Biological Evaluations of Pyridyl 4,5,6,7-Tetrahydro-4,7-Methanobenzo[d]isoxazoles as Potent and Selective Inhibitors of 11β-Hydroxylase., 65 (17.0): [PMID:35975976] [10.1021/acs.jmedchem.2c01037] |
Source
Source(1):